Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:1768-1771
Published online before print April 1, 2002, doi: 10.1161/01.CIR.0000015606.69079.27
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/15/1768    most recent
01.CIR.0000015606.69079.27v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferri, C.
Right arrow Articles by Yamani, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferri, C.
Right arrow Articles by Yamani, M. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Transplantation
Related Collections
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 2002;105:1768.)
© 2002 American Heart Association, Inc.


Brief Rapid Communications

Patterns of Myocardial Endothelin-1 Expression and Outcome After Cardiac Transplantation

Claudio Ferri, MD; Giuliana Properzi, MD; Gianluca Tomassoni, MD; Anna Santucci, MD; Giovambattista Desideri, MD; Anna Elisa Giuliani, MD; Randall C. Starling, MD, MPH; Norman B. Ratliff, MD; Daniel J. Cook, PhD; Patrick McCarthy, MD; James B. Young, MD; Mohamad H. Yamani, MD

From the University of L’Aquila, Department of Internal Medicine and Public Health (C.F., G.P., G.T., A.S., G.D., A.E.G.), Italy; and Departments of Cardiovascular Medicine (R.C.S., J.B.Y., M.H.Y.), Anatomic Pathology (N.B.R.), and Cardiothoracic Surgery (P.M.), and the Allogen Laboratory (D.J.C.), Cleveland Clinic Foundation, Ohio.

Correspondence to Mohamad H. Yamani, MD, Cleveland Clinic Foundation, Cardiovascular Medicine-F25, 9500 Euclid Ave, Cleveland, OH 44145. E-mail yamanim{at}ccf.org

Background Endothelin-1 (ET-1), a potent vasoconstrictor, is released in response to several inflammatory cytokines after heart transplantation. The present study correlated patterns of myocardial ET-1 expression in heart biopsies with acute rejection, post-transplantation ischemic injury, and subsequent development of coronary vasculopathy.

Methods and Results Patterns of myocardial ET-1 expression were evaluated in 47 heart transplant recipients at 3 months after transplant. Transplant vasculopathy was documented by coronary angiography at 2 years after transplant. Expression of ET-1 was tabulated for both blood vessels and the interstitium. Vascular ET-1 expression was positive in 7/17 (41%) of patients with greater than grade 2 (International Society Heart Lung Transplant) rejection compared with 3/30 (10%) of patients with grade 0 and grade 1A rejection (P=0.02). Compared with patients with negative interstitial ET-1 expression (n=22), patients with positive interstitial ET-1 expression (n=25) had higher incidence of post-transplantation ischemic injury (52% versus 9%, P=0.002), lower mean episodes of acute rejection (>= grade 2) during the first 3 months of transplant (1.09±0.66 versus 1.86±1.6, P=0.048), and more common vasculopathy at 2 years (50% versus 15%, P=0.02), and they tended to have worse survival (83.2% versus 100%, P=0.058).

Conclusions Vascular ET-1 expression is likely to be associated with acute rejection. Interstitial ET-1 expression, however, is more likely to be associated with post-transplantation ischemic injury and subsequent development of coronary vasculopathy.


Key Words: endothelin • rejection • transplantation • ischemia • vasculopathy




This article has been cited by other articles:


Home page
Circ Heart FailHome page
E. Larose, D. Behrendt, S. Kinlay, A. P. Selwyn, P. Ganz, and J. C. Fang
Endothelin-1 Is a Key Mediator of Coronary Vasoconstriction in Patients With Transplant Coronary Arteriosclerosis
Circ Heart Fail, September 1, 2009; 2(5): 409 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. W.M. Fedak, V. Rao, S. Verma, D. Ramzy, L. Tumiati, S. Miriuka, P. Boylen, R. D. Weisel, and C. M. Feindel
Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation
J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 407 - 415.
[Abstract] [Full Text] [PDF]